Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPRR1B - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
GEO DataSets Gene Profile neighbors Chromosome neighbors
SPRR3 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SPRR2B - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
SPRR1A - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
SPRR4 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
LINC01527 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
SPRR2C - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
IVL - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
SPRR2G - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
SMCP - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
LOC101928009 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
LELP1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
PRR9 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
LCE1B - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
LOR - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
LCE1E - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
PGLYRP3 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
PGLYRP4 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on